Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells

被引:52
|
作者
AlAoukaty, A
Schall, TJ
Maghazachi, AA
机构
[1] UNIV OSLO,DEPT ANAT,N-0317 OSLO,NORWAY
[2] UNIV OTTAWA,DEPT MED,OTTAWA,ON,CANADA
[3] DNAX RES INST MOLEC & CELLULAR BIOL INC,PALO ALTO,CA
关键词
D O I
10.1182/blood.V87.10.4255.bloodjournal87104255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using two different approaches, we have investigated the types of G proteins coupled to CC chemokine receptors. First, permeabilization of interleukin-2-activated natural killer (IANK) cells with streptolysin-O and introduction of anti-G protein antibodies inside these cells resulted in the following. (1) Anti-G(s), anti-G(o), and anti-G(z) inhibited the migration of IANK cells in response to macrophage-inflammatory protein-1 alpha (MIP-1 alpha), monocyte chemoattractant protein-1 (MCP-1), or regulated on activation normal T cell expressed and secreted (RANTES). (2) Anti-G(i) inhibited their migration in response to MCP-1 or RANTES but not in response to MIP-1 alpha. Second, incubation of IANK cell membranes with anti-G protein antibodies before incubating with (gamma-S-35) GTP or (gamma-P-32) GTP, resulted in the following. (1) Anti-G(s), anti-G(o), or anti-G(z) inhibited GTP binding and GTPase activity in the presence of MIP-1 alpha, MCP-1, or RANTES. (2) Anti-G(i) inhibited GTP binding and GTPase activity in the presence of MCP-1 or RANTES but not in the presence of MIP-1 alpha. The inhibitory effect of anti-G protein antibodies was reversed upon incubating these antibodies with their respective synthetic peptides before addition to IANK cell membranes. These results suggest that MCP-1 and RANTES receptors are promiscuously coupled to multiple G proteins in IANK cell membranes and that this coupling is different from MIP-1 alpha receptors, which seem to be coupled to G(s), G(o), and G(z) but not to G(i). (C) 1996 by The American Society of Hematology.
引用
收藏
页码:4255 / 4260
页数:6
相关论文
共 50 条
  • [31] ANALYSIS OF INTERLEUKIN-2-ACTIVATED KILLER-CELLS OF RHESUS-MONKEYS - STRIKING RESEMBLANCE TO THE HUMAN SYSTEM
    SAVARY, CA
    LOTZOVA, E
    JACKSON, HJ
    JARDINE, JH
    ANG, KK
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (04) : 307 - 313
  • [32] CYTOTOXIC ACTIVITY AGAINST HIV-INFECTED MONOCYTES BY RECOMBINANT INTERLEUKIN-2-ACTIVATED NATURAL-KILLER-CELLS
    MELDER, RJ
    BALACHANDRAN, R
    RINALDO, CR
    GUPTA, P
    WHITESIDE, TL
    HERBERMAN, RB
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (08) : 1011 - 1015
  • [33] INTERLEUKIN-2-ACTIVATED NATURAL-KILLER-CELLS CAN SUPPORT HEMATOPOIESIS INVITRO AND PROMOTE MARROW ENGRAFTMENT INVIVO
    MURPHY, WJ
    KELLER, JR
    HARRISON, CL
    YOUNG, HA
    LONGO, DL
    BLOOD, 1992, 80 (03) : 670 - 677
  • [34] THE EFFECTS OF RECOMBINANT INTERLEUKIN-2-ACTIVATED NATURAL-KILLER CELLS ON AUTOLOGOUS PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS
    NAGLER, A
    GREENBERG, PL
    LANIER, LL
    PHILLIPS, JH
    JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01): : 47 - 54
  • [35] Effect of heat-pretreatment on interleukin-2-activated killer cells for in vitro purging
    Tanaka, M
    Honda, J
    Imamura, Y
    Shiraishi, K
    Tanaka, K
    Oizumi, K
    PATHOBIOLOGY, 2000, 68 (03) : 124 - 128
  • [36] Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: Comparisons of antitumor effects in vitro and in vivo
    Whiteside, TL
    Sung, MW
    Nagashima, S
    Chikamatsu, K
    Okada, K
    Vujanovic, NL
    CLINICAL CANCER RESEARCH, 1998, 4 (05) : 1135 - 1145
  • [37] LONG-TERM KILLING OF NATURAL KILLER-RESISTANT TARGET-CELLS BY INTERFERON-ALPHA-ACTIVATED, INTERFERON-GAMMA-ACTIVATED, AND INTERLEUKIN-2-ACTIVATED NATURAL-KILLER CELLS
    SARZOTTI, M
    KLIMPEL, GR
    BARON, S
    NATURAL IMMUNITY AND CELL GROWTH REGULATION, 1989, 8 (02) : 66 - 75
  • [38] Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: Roles of cell surface molecules and intracellular events
    Yamauchi, A
    Taga, K
    Mostowski, HS
    Bloom, ET
    BLOOD, 1996, 87 (12) : 5127 - 5135
  • [39] INHIBITION BY FIBRIN COAGULATION OF LUNG-CANCER CELL DESTRUCTION BY HUMAN INTERLEUKIN-2-ACTIVATED KILLER-CELLS
    ATAGI, S
    SONE, S
    FUKUTA, K
    OGURA, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (10): : 1088 - 1094
  • [40] SYNERGISM BETWEEN ALPHA-INTERFERON AND INTERLEUKIN-2-ACTIVATED KILLER CELLS - INVITRO STUDIES
    DIRAIMONDO, F
    LAPUSHIN, R
    HERSH, EM
    ACTA HAEMATOLOGICA, 1987, 78 : 77 - 83